Intravitreal aflibercept in routine clinical practice: 24-month results from the global treatment-naive cohort with macular edema secondary to central retinal vein occlusion in the AURIGA study

被引:0
|
作者
Giocanti-Auregan, Audrey [1 ]
Yang, Chang-Hao [2 ]
Donati, Simone [3 ]
Allmeier, Helmut [4 ]
Machewitz, Tobias [5 ]
Rittenhouse, Kay D. [6 ]
Hoerauf, Hans [7 ]
机构
[1] Sorbonne Paris Nord Univ, Hop Avicenne, Bobigny, France
[2] Natl Taiwan Univ Hosp, Dept Ophthalmol & Coll Med, Taipei, Taiwan
[3] Univ Insubria, Dept Med & Surg, Varese, Italy
[4] Bayer Consumer Care AG, Basel, Switzerland
[5] Bayer AG, Berlin, Germany
[6] Bayer US LLC, Whippany, NJ USA
[7] Univ Med Gottingen, Augenklin, Gottingen, Germany
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1762
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Intravitreal aflibercept in routine clinical practice: 24-month results from the global cohort of pretreated patients with diabetic macular edema in the AURIGA study
    Donati, Simone
    Mura, Marco
    Giocanti-Auregan, Audrey
    Hoerauf, Hans
    Yang, Chang-Hao
    Allmeier, Helmut
    Machewitz, Tobias
    Santoro, Elina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [2] Aflibercept in a real-world setting: the AURIGA study 24-month results of the German cohort of treatment-naive patients with macular edema following retinal vein occlusion receiving intravitreal aflibercept
    Wachtlin, Joachim
    Kaymak, Hakan
    Hoerauf, Hans
    Allmeier, Helmut
    Machewitz, Tobias
    Scholz, Paula
    Schuerks, Markus
    Feltgen, Nicolas
    OPHTHALMOLOGIE, 2024, 121 (08): : 650 - 657
  • [3] Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study
    Donati, Simone
    Yang, Chang-Hao
    Xu, Xun
    Mura, Marco
    Giocanti-Auregan, Audrey
    Hoerauf, Hans
    Allmeier, Helmut
    Machewitz, Tobias
    Johnson, Kristian T.
    Santoro, Elina
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (01) : 161 - 178
  • [4] Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study
    Simone Donati
    Chang-Hao Yang
    Xun Xu
    Marco Mura
    Audrey Giocanti-Aurégan
    Hans Hoerauf
    Helmut Allmeier
    Tobias Machewitz
    Kristian T. Johnson
    Elina Santoro
    Ophthalmology and Therapy, 2024, 13 : 161 - 178
  • [5] Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study
    Audrey Giocanti-Aurégan
    Simone Donati
    Hans Hoerauf
    Helmut Allmeier
    Kay D. Rittenhouse
    Tobias Machewitz
    Chang-Hao Yang
    Ophthalmology and Therapy, 2024, 13 : 179 - 203
  • [6] Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study
    Giocanti-Auregan, Audrey
    Donati, Simone
    Hoerauf, Hans
    Allmeier, Helmut
    Rittenhouse, Kay D.
    Machewitz, Tobias
    Yang, Chang-Hao
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (01) : 179 - 203
  • [7] Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month Outcomes
    Shimura, Masahiko
    Fukumatsu, Makoto
    Tsujimura, Jun
    Hirano, Kazufumi
    Sunaya, Toshiyuki
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 579 - 592
  • [8] Aflibercept in the clinical routine: the AURIGA study. The 24-month results of the German cohort of treatment-naïve patients with diabetic macular edema receiving intravitreal aflibercept
    Ulbig, Michael
    Brinkmann, Christian Karl
    Mirshahi, Alireza
    Hoerauf, Hans
    Allmeier, Helmut
    Machewitz, Tobias
    Scholz, Paula
    Keramas, Georgios
    Khoramnia, Ramin
    OPHTHALMOLOGIE, 2024, 121 (11): : 894 - 903
  • [9] Intravitreal aflibercept use in the treatment of macular edema from central retinal vein occlusion
    Carle, Michelle V.
    Chu, Thomas G.
    Tabandeh, Homayoun
    Boyer, David S.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2013, 8 (03) : 227 - 235
  • [10] Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study
    Ogura, Yuichiro
    Roider, Johann
    Korobelnik, Jean-Francois
    Holz, Frank G.
    Simader, Christian
    Schmidt-Erfurth, Ursula
    Vitti, Robert
    Berliner, Alyson J.
    Niemeyer, Florian
    Stemper, Brigitte
    Zeitz, Oliver
    Sandbrink, Rupert
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 158 (05) : 1032 - 1038